Schedule 13D ownership disclosure
Freeline Therapeutics Holdings plc
Security class unavailable · CUSIP: G3664N103
Event date: 2024-02-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 100.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-24-042827
- Form type
- SC 13D
- Filer
- Freeline Therapeutics Holdings plc
- CIK
- CIK 1810031
- Filed
- Feb 22, 2024
- Reporting period
- Feb 20, 2024
- Description
- Schedule 13D beneficial ownership